| Literature DB >> 32076815 |
Benedikt Martin1, Bettina Monika Banner2, Eva-Maria Schäfer2, Patrick Mayr2,3, Matthias Anthuber4, Gerhard Schenkirsch5, Bruno Märkl2.
Abstract
The tumor stroma ratio (TSR) is a promising prognostic biomarker in colon cancer, which could provide additional risk stratification for therapy adaption. The objective of our study was the investigation of the prognostic significance of TSR at different tumor sites in a simple semiautomatic approach with the open-source program ImageJ. We investigated 206 pT3 and pT4 adenocarcinomas of no special type. According to our established thresholds, 31 tumors (15%) were classified as low tumor proportion (TP) (≤ 15% TP), 42 tumors (20%) were classified as high TP (≥ 54% TP), and 133 tumors (65%) were classified as medium TP. High and low TP were associated with an adverse overall survival in comparison to medium TP (p = 0.001 and p = 0.03). Furthermore, the TP was an independent risk factor of occurrence of distant metastasis next to T status, microsatellite status, and tumor budding. The 5-year survival rate was 49% in patients with high TP, 48% in patients with low TP, and 68% in patients with medium TP (p = 0.042, n = 160). Patients with a high TP had less often tumor budding (p = 0.012), lymphovascular invasion (p = 0.049), and less harvested lymph nodes (p = 0.042) in comparison to low TP tumors. The results provide first evidence that a high tumor proportion/low stroma proportion is also associated with an adverse prognosis and that this subgroup might be difficult to identify with other classical histopathologic characteristics that are linked to an adverse prognosis.Entities:
Keywords: Biomarker; Colon cancer; ImageJ; Tumor stroma ratio
Mesh:
Year: 2020 PMID: 32076815 PMCID: PMC7985049 DOI: 10.1007/s00428-020-02764-1
Source DB: PubMed Journal: Virchows Arch ISSN: 0945-6317 Impact factor: 4.064